(Q42204205)

18 October 2017

title

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. (English)

1 reference

18 October 2017

0 references

5

Nicole Le Saux

0 references

Manish Sadarangani

Manish Sadarangani

1

0 references

Julie Bettinger

Julie A Bettinger

7

0 references

David W Scheifele

David W Scheifele

2

0 references

Wendy Vaudry

4

Wendy Vaudry

1 reference

18 October 2017

3

Scott A Halperin

1 reference

18 October 2017

Raymond Tsang

6

1 reference

18 October 2017

investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT)

8

1 reference

18 October 2017

language of work or name

English

0 references

publication date

28 July 2014

1 reference

Clinical Infectious Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

59

1 reference

18 October 2017

issue

9

1 reference

18 October 2017

page(s)

1208-1215

1 reference

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU597

21 January 2018

Identifiers

DOI

10.1093/CID/CIU597

1 reference

18 October 2017

1 reference